![Hampus Darrell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hampus Darrell
Financieel Directeur/CFO bij
PILA PHARMA AB
Profiel
Hampus Darrell currently works at BPC Instruments AB, as Chief Financial Officer from 2025 and Pila Pharma AB, as Chief Financial Officer from 2024.
Mr. Darrell also formerly worked at Setterwalls Advokatbyrå AB, as Chief Financial Officer from 2019 to 2024.
Mr. Darrell received his graduate degree in 2001 from the University of Lund.
Actieve functies van Hampus Darrell
| Bedrijven | Functie | Begin |
|---|---|---|
| PILA PHARMA AB | Financieel Directeur/CFO | 17-12-2024 |
| BPC INSTRUMENTS AB | Financieel Directeur/CFO | 07-05-2025 |
Eerdere bekende functies van Hampus Darrell
| Bedrijven | Functie | Einde |
|---|---|---|
Setterwalls Advokatbyrå AB
 Setterwalls Advokatbyrå AB Miscellaneous Commercial ServicesCommercial Services Provides legal advisory services | Financieel Directeur/CFO | 01-01-2024 |
Opleiding van Hampus Darrell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Setterwalls Advokatbyrå AB
Setterwalls Advokatbyrå AB Miscellaneous Commercial ServicesCommercial Services Provides legal advisory services | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPC Instruments AB
 BPC Instruments AB Electronic Equipment/InstrumentsElectronic Technology Provides control technologies for the commercial bio-gas industry | Electronic Technology |
Pila Pharma AB
 Pila Pharma AB BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company which develops oral anti-diabetic agents | Health Technology |
